INGNInogen Inc
Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Revenue
- $295M
- 5.9% YoY
- Operating margin
- -10.2%
- 33% YoY
- EBITDA
- −$10M
- 56% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- —
- −$87M net debt
- AI in 10-K
- —
Red flags 1 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashFired-49% of net incomeCash flow under 80% of net income
- Dilutive SBCClear3% of revenueOver 10% of revenue
- Payouts exceed cash flowClear0% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear4% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $312M | $321M | $252M | $279M | $295M | 5.9% |
| Operating income | $9M | −$85M | −$109M | −$43M | −$30M | 29% |
| Net income | $6M | $84M | $102M | $36M | $23M | 37% |
| Operating cash flow | $24M | −$38M | −$3M | $6M | −$11M | 290% |
| Capex | $5M | $3M | $5M | $3M | $3M | 25% |
| Stock-based comp | $11M | $12M | $7M | $7M | $8M | 8.3% |
Deal filings
None.
13D filers
None on file.
Insider trading
No open-market trades in the last 12 months.
Pay vs performance
| Year | CEO total comp | Comp actually paid | TSR (indexed) | Peer TSR |
|---|---|---|---|---|
| FY2025 | — | — | 15 | 78 |
| FY2024 | — | — | 21 | 78 |
| FY2023 | — | — | 12 | 74 |
| FY2022 | — | — | 44 | 79 |
| FY2021 | — | — | 76 | 103 |